Cargando…

An Evidence-based Physical Therapy Prescription for Adults With X-linked Hypophosphatemia

CONTEXT: X-linked hypophosphatemia (XLH) is a rare and progressive metabolic phosphate-wasting disorder characterized by lifelong musculoskeletal comorbidities. Despite considerable physical disability, there are currently no disease-specific physical therapy (PT) recommendations for XLH designed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanamalla, Karthik, Fuchs, Rebekah, Herzog, Casey, Steigbigel, Keith D, Macica, Carolyn M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249973/ https://www.ncbi.nlm.nih.gov/pubmed/35795809 http://dx.doi.org/10.1210/jendso/bvac094

Ejemplares similares

Creation of an Evidence-Based Physical Therapy Program for Adults with XLH: Translational Application of an Interprofessional Clinical Study
por: Kanamalla, Karthik, et al.
Publicado: (2021)

Osteoarthritis, Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia
por: Steele, Amy, et al.
Publicado: (2020)

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey
por: Skrinar, Alison, et al.
Publicado: (2019)

Biomechanical Impact of Phosphate Wasting on Articular Cartilage Using the Murine Hyp Model of X‐linked hypophosphatemia
por: Macica, Carolyn M, et al.
Publicado: (2023)

Growth Curves for Children with X-linked Hypophosphatemia
por: Mao, Meng, et al.
Publicado: (2020)

X-linked Hypophosphatemia (XLH) Mimicking Rheumatic Disease
por: Takase, Ryosuke, et al.
Publicado: (2020)

Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia
por: Weber, Thomas J, et al.
Publicado: (2022)

Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations
por: Chesher, Douglas, et al.
Publicado: (2018)

Dental management of patients with X-linked hypophosphatemia
por: Lee, Bin-Na, et al.
Publicado: (2017)

Enthesopathy, Osteoarthritis, and Mobility in X-linked Hypophosphatemia
por: Imel, Erik A
Publicado: (2020)

Genotype and Phenotype Analysis in X-Linked Hypophosphatemia
por: Park, Peong Gang, et al.
Publicado: (2021)

Impact of X-Linked Hypophosphatemia on Muscle Symptoms
por: Romagnoli, Cecilia, et al.
Publicado: (2022)

An adult patient of X-linked hypophosphatemia with joint manifestation mimicking spondylarthritis
por: Wang, Chuhan, et al.
Publicado: (2022)

Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children
por: Schindeler, Aaron, et al.
Publicado: (2020)

Autism and X-linked hypophosphatemia: A possible association?
por: Joël, Vermeersch, et al.
Publicado: (2010)

SUN-526 Prevalence of Hyperparathyroidism in X-Linked Hypophosphatemia
por: DeLacey, Sean, et al.
Publicado: (2019)

X-Linked Hypophosphatemia: A New Era in Management
por: Dahir, Kathryn, et al.
Publicado: (2020)

Burosumab and Dental Abscesses in Children With X‐Linked Hypophosphatemia
por: Gadion, Margaux, et al.
Publicado: (2022)

Craniosynostosis in Patients With X‐Linked Hypophosphatemia: A Review
por: Munns, Craig F, et al.
Publicado: (2023)

Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X‐Linked Hypophosphatemia: A Phase 3, Single‐Arm, International Trial
por: Insogna, Karl L, et al.
Publicado: (2019)

Population Pharmacokinetics and Pharmacodynamics of Burosumab in Adult and Pediatric Patients With X‐linked Hypophosphatemia
por: Lee, Sun Ku, et al.
Publicado: (2021)

Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia
por: Zhukouskaya, Volha V, et al.
Publicado: (2020)

Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population
por: Rodríguez-Rubio, Enrique, et al.
Publicado: (2021)

Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
por: Laurent, Michaël R., et al.
Publicado: (2021)

Erratum to: “X-Linked Hypophosphatemia: A New Era in Management”
Publicado: (2021)

Serum Levels of Lipocalin Are Lower in Adolescents With X-Linked Hypophosphatemia
por: Simpson, Christine A, et al.
Publicado: (2021)

Health-related quality of life of X-linked hypophosphatemia in Spain
por: Yanes, M. I. Luis, et al.
Publicado: (2022)

Ossification of the Posterior Longitudinal Ligament Caused by X-linked Hypophosphatemia
por: Yamamoto, Koichiro, et al.
Publicado: (2023)

Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis
por: Hawley, Samuel, et al.
Publicado: (2019)

Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia
por: Linglart, Agnès, et al.
Publicado: (2021)

SUN-336 Obesity and Impaired Glucose Metabolism in Adult Patients with X-Linked Hypophosphatemia
por: Lecoq, Anne-Lise, et al.
Publicado: (2020)

Lower Limb Deformity and Gait Deviations Among Adolescents and Adults With X-Linked Hypophosphatemia
por: Mindler, Gabriel T., et al.
Publicado: (2021)

Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data
por: Javaid, Muhammad Kassim, et al.
Publicado: (2021)

Lower limb bone geometry in adult individuals with X-linked hypophosphatemia: an observational study
por: Scorcelletti, Matteo, et al.
Publicado: (2022)

First‐in‐Asian Phase I Study of the Anti‐Fibroblast Growth Factor 23 Monoclonal Antibody, Burosumab: Safety and Pharmacodynamics in Adults With X‐linked Hypophosphatemia
por: Cheong, Hae Il, et al.
Publicado: (2018)

Burosumab in X-linked hypophosphatemia: a profile of its use in the USA
por: Lyseng-Williamson, Katherine A.
Publicado: (2018)

FGF23 and its role in X-linked hypophosphatemia-related morbidity
por: Beck-Nielsen, Signe Sparre, et al.
Publicado: (2019)

Correction to: Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population
por: Rodríguez-Rubio, Enrique, et al.
Publicado: (2021)

Clinical and Genetic Characteristics of 153 Chinese Patients With X-Linked Hypophosphatemia
por: Lin, Xiaoyun, et al.
Publicado: (2021)

Corrigendum: Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
por: Laurent, Michaël R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4v95mfdhp6jk2d51d72dm70lqs